Skip to Main content Skip to Navigation
Theses

Influence des protéines d’enveloppe du virus de l’hépatite B sur la disparition de l’antigène HBs circulant lors du traitement de l’hépatite chronique B par analogues nucléos(t)idiques : mécanismes moléculaires impliqués et développement d’un traitement immunomodulateur à base d’anticorps monoclonaux

Abstract : Hepatitis B virus (HBV)-related chronic infection remains difficult to eradicate. On treatment by nucleos(t)ide analogues (NUCs), HBs Antigen (Ag) clearance is the ultimate but difficult therapeutic goal. Our aim was to investigate how variability of HBV envelope protein, crucial in viral cellular entry and targeted by host immune response, could play a role in HBsAg clearance. HBV chronically infected patients, treated by NUCs with HBsAg clearance (resolver) were matched with patients without HBsAg clearance (non resolver). Combined mutations sT125M/sP127T, associated with HBsAg persistence, displayed a lower predicted antigenicity. Ultra Deep Sequencing of S gene showed a higher variability in non resolver. Functional assays on viral particles including sT125M and sP127T mutations versus reference particles are in progress. As a conclusion, molecular features observed in non NR argue in favor of a different pattern in HBV S characteristics according to variable NUCs efficiency
Document type :
Theses
Complete list of metadatas

Cited literature [155 references]  Display  Hide  Download

https://hal.univ-lorraine.fr/tel-01754577
Contributor : Thèses Ul <>
Submitted on : Friday, March 30, 2018 - 9:53:49 AM
Last modification on : Tuesday, October 13, 2020 - 10:46:38 AM

File

DDOC_T_2015_0284_VELAY_RUSCH.p...
Files produced by the author(s)

Identifiers

  • HAL Id : tel-01754577, version 1

Citation

Aurélie Rusch-Velay. Influence des protéines d’enveloppe du virus de l’hépatite B sur la disparition de l’antigène HBs circulant lors du traitement de l’hépatite chronique B par analogues nucléos(t)idiques : mécanismes moléculaires impliqués et développement d’un traitement immunomodulateur à base d’anticorps monoclonaux. Médecine humaine et pathologie. Université de Lorraine, 2015. Français. ⟨NNT : 2015LORR0284⟩. ⟨tel-01754577⟩

Share

Metrics

Record views

87

Files downloads

1157